The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Adipose Tissue Has Aberrant Morphology and Function in PCOS: Enlarged Adipocytes and Low Serum Adiponectin, But Not Circulating Sex Steroids, Are Strongly Associated with Insulin Resistance
Abstract
CONTEXT: Comprehensive characterization of the adipose tissue in women with polycystic ovary syndrome (PCOS), over a wide range of body mass indices (BMIs), is lacking. Mechanisms behind insulin resistance in PCOS are unclear. OBJECTIVE: To characterize the adipose tissue of women with PCOS and controls matched pair-wise for age and BMI, and to identify factors, among adipose tissue characteristics and serum sex steroids, that are associated with insulin sensitivity in PCOS. DESIGN/OUTCOME MEASURES: Seventy-four PCOS women and 31 controls were included. BMI was 18-47 (PCOS) and 19-41 kg/m(2) (controls). Anthropometric variables, volumes of subcutaneous/visceral adipose tissue (magnetic resonance imaging; MRI), and insulin sensitivity (clamp) were investigated. Adipose tissue biopsies were obtained to determine adipocyte size, lipoprotein lipase (LPL) activity, and macrophage density. Circulating testosterone, free testosterone, free 17β-estradiol, SHBG, glycerol, adiponectin, and serum amyloid A were measured/calculated. RESULTS: Comparison of 31 pairs revealed lower insulin sensitivity, hyperandrogenemia, and higher free 17β-estradiol in PCOS. Abdominal adipose tissue volumes/distribution did not differ in the groups, but PCOS women had higher waist-to-hip ratio, enlarged adipocytes, reduced adiponectin, and lower LPL activity. In regression analysis, adipocyte size, adiponectin, and waist circumference were the factors most strongly associated with insulin sensitivity in PCOS (R(2)=0.681, P < 0.001). CONCLUSIONS: In PCOS, adipose tissue has aberrant morphology/function. Increased waist-to-hip ratio indicates abdominal/visceral fat accumulation, but this is not supported by MRI. Enlarged adipocytes and reduced serum adiponectin, together with a large waistline, rather than androgen excess, may be central factors in the pathogenesis/maintenance of insulin resistance in PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In PCOS, hypertrophic adipocytes are associated with metabolic disorders [37].”
From The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome (2022) · cites this paper as [37]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
Adiponectin and Adiponectin Receptors
Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,167
Lawrence, J., Douglas, P., & Gandy, J. (2016) · doi:10.1002/9781119163411.ch73 · Cited by 1,014
Cited by
Sorted by citations
Items 101–200 of 368
Keller, E., Chazenbalk, G. D., Aguilera, P., Madrigal, V., Grogan, T., Elashoff, D., Dumesic, D. A., & Abbott, D. H. (2014) · Endocrinology · doi:10.1210/en.2014-1050 · Cited by 60
Feng, Y., Tang, Z., & Zhang, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115470 · Cited by 63
Lin, L., Du, T., Huang, J., Huang, L., & Yang, D. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.149189 · Cited by 60
Cox, M. J., Edwards, M. C., Paris, V. R., Aflatounian, A., Ledger, W. J., Gilchrist, R. B., Padmanabhan, V., Handelsman, D. J., & Walters, K. A. (2020) · Endocrinology · doi:10.1210/endocr/bqaa061 · Cited by 59
Jedel, E., Gustafson, D., Wærn, M., Sverrisdóttir, Y. B., Landén, M., Janson, P. O., Labrie, F., Ohlsson, C., & Stener‐Victorin, E. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.04.001 · Cited by 57
Obesity and insulin resistance in children
Tagi, V. M., & Chiarelli, F. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000913 · Cited by 58
Ayonrinde, O. T., Adams, L. A., Doherty, D. A., Mori, T. A., Beilin, L. J., Oddy, W. H., Hickey, M., Sloboda, D. M., Olynyk, J. K., & Hart, R. J. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13241 · Cited by 55
Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity
Calcaterra, V., Rossi, V., Massini, G., Casini, F., Zuccotti, G., & Fabiano, V. (2023) · Nutrients · doi:10.3390/nu15143144 · Cited by 64
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 55
Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes
Cioana, M., Deng, J., Nadarajah, A., Hou, M., Qiu, Y., Chen, S. S. J., Rivas, A., Banfield, L. E., Alfaraidi, H., Alotaibi, A., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.47454 · Cited by 55
Immune Dysfunction in Polycystic Ovary Syndrome
Banerjee, S., Cooney, L. G., & Stanic, A. K. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200033 · Cited by 52
Spinedi, E., & Cardinali, D. P. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1349868 · Cited by 52
Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities
Zhang, Y., Chen, Z., & Zhao, H. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.08.002 · Cited by 62
Glintborg, D., Petersen, M. H., Ravn, P., Hermann, A. P., & Andersen, M. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12964 · Cited by 53
Kokosar, M., Benrick, A., Perfilyev, A., Nilsson, E., Källman, T., Ohlsson, C., Ling, C., & Stener‐Victorin, E. (2018) · Scientific Reports · doi:10.1038/s41598-017-17919-5 · Cited by 51
Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome
Pau, C. T., Mosbruger, T., Saxena, R., & Welt, C. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168870 · Cited by 51
Metabolic Syndrome in Polycystic Ovary Syndrome
Pasquali, R. (2018) · Frontiers of hormone research · doi:10.1159/000485995 · Cited by 49
The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome
Bourgneuf, C., Bailbé, D., Lamazière, A., Dupont, C., Moldes, M., Farabos, D., Roblot, N., Gauthier, C., d’Argent, E. M., Cohen-Tannoudji, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21308-y · Cited by 53
Yao, K., Bian, C., & Zhao, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4642 · Cited by 48
Kataoka, J., Larsson, I., Björkman, S., Eliasson, B., Schmidt, J., & Stener‐Victorin, E. (2019) · Clinical Endocrinology · doi:10.1111/cen.14098 · Cited by 48
Stener‐Victorin, E., Baghaei, F., Holm, G., Janson, P. O., Olivecrona, G., Lönn, M., & Mannerås-Holm, L. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.010 · Cited by 48
Endocrinology and Gynecology of Girls and Women with Low Birth Weight
Ibáñez, L., López‐Bermejo, A., Díaz, M., & Marcos, M. V. (2011) · Fetal Diagnosis and Therapy · doi:10.1159/000330366 · Cited by 46
Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens
Cardozo, L. L. Y., Romero, D. G., & Reckelhoff, J. F. (2017) · Physiology · doi:10.1152/physiol.00030.2016 · Cited by 48
Mannerås-Holm, L., Benrick, A., & Stener‐Victorin, E. (2014) · Adipocyte · doi:10.4161/adip.28731 · Cited by 43
Benrick, A., Maliqueo, M. A., Sun, M., Villanueva, J. A., Feng, Y., Ohlsson, C., Dulęba, A. J., & Stener‐Victorin, E. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/964070 · Cited by 45
Hurliman, A. K., Brown, J. K., Maille, N., Mandalà, M., Casson, P. R., & Osol, G. (2015) · Endocrinology · doi:10.1210/en.2015-1159 · Cited by 44
Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health
Brennan, K. M., Kroener, L. L., Chazenbalk, G. D., & Dumesic, D. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000661 · Cited by 44
Ezeh, U. I., Chen, I. Y.-D., Chen, Y., & Azziz, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa235 · Cited by 46
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Polycystic Ovary Syndrome as a Paradigm for Prehypertension, Prediabetes, and Preobesity
Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0500-6 · Cited by 44
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 41
Ibáñez, L., Díaz, M., Sebastiani, G., Sánchez‐Infantes, D., Salvador, C., López‐Bermejo, A., & de Zegher, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1671 · Cited by 42
Zhu, S., Li, Z., Hu, C., Sun, F., Wang, C., Yuan, H., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.697223 · Cited by 41
Ezeh, U. I., Pall, M., Mathur, R., Dey, D., Berman, D. S., Chen, Y. I., Dumesic, D. A., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2937 · Cited by 41
PCOS in Adolescence and Type 2 Diabetes
Carreau, A.-M., & Baillargeon, J.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0564-3 · Cited by 40
Fisch, S. C., Nikou, A. F., Wright, E. A., Phan, J. D., Leung, K. L., Grogan, T., Abbott, D. H., Chazenbalk, G. D., & Dumesic, D. A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.042 · Cited by 41
Recent Update on the Molecular Mechanisms of Gonadal Steroids Action in Adipose Tissue
Wawrzkiewicz–Jałowiecka, A., Lalik, A., & Soveral, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105226 · Cited by 46
Leptin and body mass index in polycystic ovary syndrome
Jalilian, N., Haghnazari, L., & Rasolinia, S. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.180005 · Cited by 40
Epigenetic inheritance of PCOS by developmental programming and germline transmission
Stener‐Victorin, E., & Deng, Q. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.12.002 · Cited by 40
Androgens in polycystic ovary syndrome
Walters, K. A. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000245 · Cited by 39
Tola, E. N., Yalçın, S. E., & Dugan, N. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.05.014 · Cited by 39
Khorchani, M. J., Zal, F., & Neisy, A. (2019) · Reproduction Fertility and Development · doi:10.1071/rd19072 · Cited by 39
Rondanelli, M., Perna, S., Faliva, M. A., Monteferrario, F., Repaci, E., & Allieri, F. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3433-z · Cited by 44
Update on Animal Models of Polycystic Ovary Syndrome
Stener‐Victorin, E. (2022) · Endocrinology · doi:10.1210/endocr/bqac164 · Cited by 40
Androgens Modulate the Immune Profile in a Mouse Model of Polycystic Ovary Syndrome
Torstensson, S., Ascani, A., Risal, S., Lu, H., Zhao, A., Espinosa, A., Lindgren, E., Johansson, M. H., Eriksson, G., Barakat, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202401772 · Cited by 38
Complementary Therapy in Polycystic Ovary Syndrome
Aquino, C. I., & Nori, S. L. (2014) · Europe PMC (PubMed Central) · doi:10.14273/unisa-247 · Cited by 37
Leonhardt, H., Gull, B., Stener-Victorin, E., & Hellström, M. (2014) · Acta Radiologica · doi:10.1177/0284185113495835 · Cited by 35
Zheng, R., Shen, H., Li, J., Zhao, J., Lu, L., Hu, M., Lin, Z., Ma, H., Tan, H., Hu, M., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115824 · Cited by 35
Varlamov, O., Bishop, C. V., Handu, M., Takahashi, D., Srinivasan, S., White, A., & Roberts, C. T. (2017) · Human Reproduction · doi:10.1093/humrep/dex244 · Cited by 34
Trottier, A., Battista, M., Geller, D. H., Moreau, B., Carpentier, A. C., Simoneau‐Roy, J., & Baillargeon, J. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.025 · Cited by 34
Leonhardt, H., Hellström, M., Gull, B., Lind, A., Nilsson, L., Janson, P., & Stener-Victorin, E. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.022 · Cited by 32
Stener‐Victorin, E., Maliqueo, M. A., Soligo, M., Protto, V., Manni, L., Jerlhag, E., Kokosar, M., Sazonova, A. P., Behre, C. J., Lind, M., et al. (2016) · Obesity Science & Practice · doi:10.1002/osp4.78 · Cited by 32
Lionett, S., Kiel, I. A., CAMERA, D. M., Vanky, E., Parr, E. B., Lydersen, S., Hawley, J. A., & Moholdt, T. T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00904 · Cited by 33
Lerner, A., Kewada, D., Ahmed, A., Hardy, K., Christian, M., & Franks, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010243 · Cited by 33
Marino, J. S., Iler, J., Dowling, A. R., Chua, S. C., Brüning, J. C., Coppari, R., & Hill, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048643 · Cited by 31
The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review
Merlo, E., Silva, I. V., Cardoso, R. C., & Graceli, J. B. (2018) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2018.1496214 · Cited by 32
Shanaki, M., Moradi, N., Fadaei, R., Zandieh, Z., Shabani, P., & Vatannejad, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208059 · Cited by 31
Ostinelli, G., Laforest, S., Denham, S. G., Gauthier, M.-F., Drolet-Labelle, V., Scott, E., Hould, F.-S., Marceau, S., Homer, N. Z. M., Bégin, C., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac261 · Cited by 30
Shorakae, S., Abell, S. K., Hiam, D., Lambert, É., Eikelis, N., Jona, E., Sari, C. I., Stepto, N. K., Lambert, G. W., de Courten, B. V., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.11.020 · Cited by 30
Reproductive alterations in hyperinsulinemic but normoandrogenic MSG obese female rats
Gaspar, R. S., Benevides, R. O. A., Fontelles, J. L. D. L., Vale, C. C., França, L. M., Barros, P. D. T. S., & Paes, A. M. D. A. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0453 · Cited by 30
The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis
Güney, G., Taşkın, M. İ., Şener, N., Cenk, E. T., Dodurga, Y., Elmas, L., Çetin, O., & Sarigul, C. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00967-6 · Cited by 29
Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells
Bellanger, S., Battista, M., Fink, G. D., & Baillargeon, J. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.017 · Cited by 27
Jia, X., Wang, Y., Zhang, N., Guo, L., Zhen, X., Li, H., & Wei, L. (2015) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12793 · Cited by 29
Covington, J. D., Bajpeyi, S., Moro, C., Tchoukalova, Y. D., Ebenezer, P. J., Burk, D. H., Ravussin, É., & Redman, L. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0492 · Cited by 29
Andrisse, S., Billings, K., Xue, P., & Wu, S. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2017 · Cited by 28
Sucquart, I. E., Nagarkar, R., Edwards, M. C., Paris, V. R., Aflatounian, A., Bertoldo, M. J., Campbell, R. E., Gilchrist, R. B., Begg, D. P., Handelsman, D. J., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab020 · Cited by 28
Maliqueo, M. A., Galgani, J. E., Pérez‐Bravo, F., Echiburú, B., de Guevara, A. L., Crisosto, N., & Sir‐Petermann, T. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.12.012 · Cited by 28
Gao, Y., Liu, H., Qiao, L., Liang, J., Yao, H., Lin, X., & Gao, Y. (2023) · Healthcare · doi:10.3390/healthcare11040562 · Cited by 31
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive physiology · doi:10.1002/j.2040-4603.2018.tb00043.x · Cited by 27
Stener‐Victorin, E. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.006 · Cited by 27
Jones, M. R., Chazenbalk, G. D., Xu, N., Chua, A. K., Eigler, T., Mengesha, E., Chen, Y.-H., Lee, J.-M., Pall, M., Li, X., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2153 · Cited by 27
Li, G., Huang, W., Zhang, L., Tian, Z., Zheng, W., Wang, T., Zhang, T., & Zhang, W. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3003 · Cited by 26
Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?
Albu, A. I., Florea, S., & Fica, S. V. (2015) · Endocrine · doi:10.1007/s12020-015-0655-1 · Cited by 26
Adiposity and metabolic dysfunction in polycystic ovary syndrome
Sam, S. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0008 · Cited by 26
Arpacı, D., Toçoğlu, A. G., Yılmaz, S., Ergenç, H., Tamer, A., Keser, N., & Gündüz, H. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0197-4 · Cited by 26
Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls
Kim, J., Choi, Y. M., Hong, M. A., Kim, M.-J., Chae, S. J., Kim, S. M., Hwang, K. R., Yoon, S. H., Ku, S., Suh, C. S., et al. (2018) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2018.61.2.253 · Cited by 26
Carbone, L., Davis, B. A., Fei, S. S., White, A. E., Nevonen, K. A., Takahashi, D. L., Vinson, A., True, C. A., Roberts, C. T., & Varlamov, O. (2019) · Scientific Reports · doi:10.1038/s41598-019-55291-8 · Cited by 27
Siemienowicz, K. J., Coukan, F., Franks, S., Rae, M. T., & Duncan, W. C. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111042 · Cited by 26
Brown Adipose Tissue Activation by Cold Treatment Ameliorates Polycystic Ovary Syndrome in Rat
Ye, R., Yan, C., Zhou, H., Huang, Y., Dong, M., Zhang, H., Jiang, X., Yuan, S., Chen, L., Jiang, R., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.744628 · Cited by 25
Mu, L., Zhao, Y., Li, R., Lai, Y.-C., & Qiao, J. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.08.007 · Cited by 25
Desai, N. A., & Patel, S. S. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1075497 · Cited by 23
Wang, W., Guo, Y. C., Zhang, X., & Zheng, J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13805 · Cited by 24
Zhuang, C., Wang, Q., Wang, W., Sun, R., Zhang, F., & Yu, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.822079 · Cited by 29
Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS
Смирнов, В. В., Beeraka, N. M., Butko, D. Y., Nikolenko, V. N., Bondarev, S., Achkasov, E. E., Sinelnikov, M. Y., & Vikram, P. R. H. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01013-x · Cited by 25
Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome
Lauria, P. B. M., Del Puerto, H. L., Reis, A. M., Candido, A. L., & Reis, F. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2141 · Cited by 23
Apoptosis in polycystic ovary syndrome: Mechanisms and therapeutic implications
Yang, L.-K., Ma, W., Wang, X., Chen, H.-R., Jiang, Y., & Sun, H. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123394 · Cited by 24
Xiong, T., Paris, V. R., Edwards, M. C., Hu, Y., Cochran, B. J., Rye, K., Ledger, W. J., Padmanabhan, V., Handelsman, D. J., Gilchrist, R. B., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00418.2021 · Cited by 22
Li, J., Wu, W., Stener‐Victorin, E., Ng, E. H. Y., Li, R., Li, M., Liu, H., Lai, M., Meng, Y., Zheng, Y., et al. (2020) · Acupuncture in Medicine · doi:10.1177/0964528420902144 · Cited by 23
Developmental programming of insulin resistance: are androgens the culprits?
Puttabyatappa, M., Sargis, R. M., & Padmanabhan, V. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0044 · Cited by 22
Lionett, S., Kiel, I. A., Røsbjørgen, R. E. N., Lydersen, S., Larsen, S., & Moholdt, T. T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.649794 · Cited by 22
Díaz, M., Chacón, M. R., López-Bermejo, A., Maymó-Masip, E., Salvador, C., Vendrell, J., de Zegher, F., & Ibáñez, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1754 · Cited by 21
Luotola, K., Piltonen, T. T., Puurunen, J., Morin-Papunen, L. C., & Tapanainen, J. S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1342793 · Cited by 21
Rodríguez‐Castelán, J., Méndez-Tepepa, M., Carrillo-Portillo, Y., Anaya‐Hernández, A., Rodríguez‐Antolín, J., Zambrano, E., Castelán, F., & Cuevas‐Romero, E. (2017) · BioMed Research International · doi:10.1155/2017/3795950 · Cited by 21
Endocrine and metabolic effects of GLP-1 receptor agonists on women with PCOS, a narrative review
Monney, M., Mavromati, M., Leboulleux, S., & Gariani, K. (2025) · Endocrine Connections · doi:10.1530/ec-24-0529 · Cited by 26
Morrison, S. A., Goss, A. M., Azziz, R., Raju, D. A., & Gower, B. A. (2016) · Human Reproduction · doi:10.1093/humrep/dew279 · Cited by 21
The corpulent phenotype—how the brain maximizes survival in stressful environments
Peters, A., Kubera, B., Hubold, C., & Langemann, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00047 · Cited by 22
Skeletal Muscle Immunometabolism in Women With Polycystic Ovary Syndrome: A Meta-Analysis
Manti, M., Stener‐Victorin, E., & Benrick, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.573505 · Cited by 18
Gharanjik, F., Shojaeifard, M. B., Karbalaei, N., & Nemati, M. (2022) · BioMed Research International · doi:10.1155/2022/7402598 · Cited by 21
Zhou, D., Li, S., Li, W., Yin, T., Xu, W., Zhang, J., & Yang, J. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.09.017 · Cited by 19
Xu, Y., Tang, J., Guo, Q., Xu, Y., Yan, K., Wu, L., Xie, K., Zhu, A., Rong, X., Ye, D., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113587 · Cited by 19
Metadata
- Authors
- Mannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., Hellström, M., Lönn, L., Olivecrona, G., Stener-Victorin, E., & Lönn, M.
- Affiliations
- University of Gothenburg (SE)
- Sahlgrenska University Hospital (SE)
- Uppsala University Hospital (SE)
- Chalmers University of Technology (SE)
- Rigshospitalet (DK)
- Umeå University (SE)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-02
- Volume
- 96
- Issue
- 2
- Pages
- E304-E311
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090371418
- Cited by
- 369
- References
- 49
- Citations by year
- 2026: 18 · 2025: 23 · 2024: 20 · 2023: 20 · 2022: 41 · 2021: 24 · 2020: 29 · 2019: 20 · 2018: 31 · 2017: 22 · 2016: 25 · 2015: 28 · 2014: 20 · 2013: 22 · 2012: 14
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Chalmers Publication Library (Chalmers University of Technology) (submittedVersion)
- Chalmers Research (Chalmers University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, insulin resistance, adipose tissue, adipocyte size, adiponectin, lipoprotein lipase, visceral adipose tissue, subcutaneous adipose tissue, waist-to-hip ratio, hyperandrogenemia, sex steroids, serum amyloid A, macrophage density, insulin sensitivity
- MeSH terms
- Adipose Tissue, Adult, Amyloid, Body Height, Body Weight, Female, Glycerol, Humans, Immunohistochemistry, Insulin Resistance, Lipoprotein Lipase, Macrophages, Polycystic Ovary Syndrome, Sex Hormone-Binding Globulin, Gonadal Steroid Hormones, Body Mass Index, Adipocytes, Cell Size, Waist-Hip Ratio, Adiponectin, Waist Circumference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
